Healthcare App Development Trends

Which healthcare app development trends are worth funding?

The healthcare app development trends worth funding are the ones a rule makes durable: SMART on FHIR apps on certified EHR APIs, payer API apps driven by CMS-0057-F, and accessibility to WCAG 2.1 AA. AI scribes and on-device models suit pilots with clinician review. Unreviewed autonomous agents can wait.

Which rules turn a trend into a requirement?

A handful of federal rules sit behind most durable healthcare app trends. Knowing their exact scope keeps a roadmap from overreaching.

• EHR APIs: 45 CFR 170.315(g)(10) requires certified health IT to offer a standardized FHIR API for patient and population services. It is a read API; writing data back needs the EHR vendor's own APIs or an HL7 v2 interface.
• Payer APIs: CMS-0057-F requires impacted payers to offer Provider Access, Payer-to-Payer and Prior Authorization APIs, and Patient Access API enhancements, from 1 January 2027.
• Device status: FDA's Clinical Decision Support Software guidance was issued on 6 January 2026 and re-issued on 29 January 2026. Its Criterion 1 excludes software that analyzes medical images or device signals from the non-device CDS carve-out.
• Non-HIPAA apps: The FTC Health Breach Notification Rule (16 CFR Part 318) covers health apps and personal health records that fall outside HIPAA, and the FTC's 2024 amendments made that coverage explicit.
• Accessibility: Under 45 CFR 84.84, recipients of HHS federal financial assistance must meet WCAG 2.1 Level AA in web content and mobile apps, from 11 May 2027 for recipients with 15 or more employees and 10 May 2028 for smaller ones.

Two newer developments also shape plans. The ASTP/ONC HTI-5 final rule, published 28 October 2026 and effective 28 December 2026, removed the predictive decision support model card and source-attribute requirements from criterion (b)(11). HHS announced in June 2026 that more than one billion health records had been exchanged through TEFCA.

App distribution has its own rule. Apple's App Store Review Guideline 1.4.1 reviews medical apps with extra scrutiny and asks developers to link to regulatory clearance documentation when the app has received it, so release plans for clinical features should include that step.

Trends to adopt now

These trends have a rule or deadline behind them and a clear buyer. Treat them as roadmap commitments, not experiments.

• SMART on FHIR read apps: Apps that launch from the EHR and read US Core data through the (g)(10) API. Hospitals already run app review processes for them. Plan write-back separately, through vendor APIs.
• Payer API integrations: For products that serve payers or use payer data, the 2027 Provider Access, Payer-to-Payer and Prior Authorization APIs set a fixed date to build against.
• Accessibility by default: Build to WCAG 2.2 AA as a design target, which also covers 2.1 AA, so provider customers can meet their 504 deadlines without a retrofit.
• Offline-first capture: Field and home care apps that store data encrypted on the device and sync with conflict rules, because clinicians often work where signal is poor.
• Granular OAuth scopes: SMART App Launch scopes that request only the resources an app needs, which shortens hospital security reviews.

What an adopt-now FHIR app needs

• Registration: An app record with each EHR vendor's developer program, such as open.epic and fhir.epic.com for Epic, with the client IDs and redirect URLs each site approves.
• Launch type: EHR launch for clinician tools and standalone launch for patient apps, since the two use different context and consent flows.
• Profiles: US Core profiles for the resources the app reads, tested against each vendor's sandbox.
• Tokens: Refresh handling and clean expiry, so a clinician is not logged out mid-task.
• Write path: A separate design for anything the app must save back, using vendor APIs or HL7 v2.

Which trends should start as pilots?

These trends can deliver value, but the evidence, rules or review process are still settling. Run them as bounded pilots with an exit decision.

• Ambient scribes: Draft notes from visit audio with a required clinician review before signing. Measure acceptance and edit rates before scaling.
• On-device models: Summarization or triage that runs on the phone. Inference on the device does not remove HIPAA duties if the input is ePHI, and any output that looks like a treatment recommendation needs a CDS review.
• Monitoring digests: Weekly or monthly trend summaries from device data for clinician review, instead of one alert per reading.
• TEFCA retrieval: For organizations connected through a QHIN, pulling outside records into the app. Check the exchange purposes your participation agreement allows.
• Patient-facing assistants: Chat tools that answer benefit or scheduling questions. Keep clinical questions routed to staff during the pilot.

Setting pilot exit criteria

Every pilot needs a measure, a target and a date, written down before it starts. For an ambient scribe, the measure might be the share of drafts accepted with minor edits. For a monitoring digest, it might be clinician review time per patient per month. When the date arrives, the owner decides to scale, change or stop, and the decision is recorded.

Which trends should wait?

These trends either lack a rule that supports them or run into one that limits them. Revisit them when the rules or evidence change.

• Unreviewed AI charting: Notes or orders filed by a model with no clinician accept step. The review is the safeguard buyers ask about first.
• Write-back through (g)(10): Plans that assume the certified API will accept writes. It is a read API, so these plans need a different integration path.
• Diagnostic chatbots for patients: Patient-facing tools fall outside the CDS carve-out, and state laws such as California's AB 3030 add disclosure duties for generative AI patient communications.
• Device-signal analysis in a general app: Interpreting ECG, imaging or other device signals inside a wellness app moves it toward FDA device rules under Criterion 1.
• Consumer apps with no breach plan: A health app outside HIPAA still faces the FTC Health Breach Notification Rule.

Signals that a waiting trend is ready

A trend in the wait group can move up when one of three things happens: a regulator publishes a rule or guidance that defines the safe path, a major EHR or payer offers the interface it depends on, or customers start asking for it in procurement. Review the wait list at each planning cycle against those signals.

How do you score a trend for your roadmap?

A short scoring pass turns a list of trends into a funded plan. Score each candidate on the same questions and keep the answers with the roadmap.

• 1. Rule: Which regulation, certification criterion or contract term makes this matter? If none, mark it as optional.
• 2. Deadline: Is there a date, such as 1 January 2027 for payer APIs or 11 May 2027 for larger 504 recipients?
• 3. Buyer: Which customer role asks for it in procurement or security review?
• 4. Integration: Which EHR, payer or device interfaces does it need, and are they read or write?
• 5. Review: Does any output need a clinician or staff review step, and who owns it?
• 6. Regulatory check: Does the feature touch FDA device rules, the FTC rule or state AI disclosure laws?
• 7. Exit: For pilots, what result ends the pilot, and who decides?

A worked example

Take an ambient scribe for a specialty clinic group. The rule question has no mandate behind it, but the buyer question is strong. Integration needs a document write path to the EHR. Review is required, owned by the signing clinician. The verdict is a pilot with acceptance-rate exit criteria.

Where trend-driven roadmaps fail

These failure points show up when a team funds trends without tying them to rules and buyers.

• No rule attached: Work justified only by a trend list is the first cut when budgets tighten.
• Scope overreach: Assuming a mandate does more than it does, such as treating (g)(10) as a write API or CMS-0057-F as covering eligibility checks.
• Pilots with no exit: A pilot that never ends becomes unmaintained production code.
• HIPAA assumptions on device: Treating on-device inference as outside HIPAA even when the input is ePHI.
• Accessibility left to the end: Retrofitting WCAG into a finished app costs more than building to it from the first screen.
• Vendor lock by accident: Building an AI feature directly against one model provider's SDK makes the next switch a rewrite. Put a thin internal gateway in front of the model from the start.
• Stale dates: Rules move. HTI-5 changed certification criteria in 2026, so check each rule's current text before each planning cycle.

How Agnotic can help

Sorting trends is a technical judgment as much as a product one, and a fractional CTO from Agnotic can make that call with your team. Agnotic Technologies reviews your roadmap against the rules and integrations each trend depends on, sets pilot exit criteria, and then builds the chosen work, from SMART on FHIR apps to review queues for AI features.

The output of a roadmap review is a short, scored list with a rule, deadline, buyer and owner beside each item, so the team can defend what it funds and what it defers.

Sources

• ASTP/ONC: Standardized API for patient and population services, 45 CFR 170.315(g)(10)
• CMS: Interoperability and Prior Authorization final rule (CMS-0057-F)
• FDA: Clinical Decision Support Software guidance (January 2026)
• eCFR: 16 CFR Part 318, Health Breach Notification Rule
• Federal Register: Extension of compliance dates for HHS Section 504 web and mobile accessibility rule
• HL7: SMART App Launch implementation guide